MDL 2785 — EpiPen (Epinephrine Injection, USP) Marketing, Sales Practices and Antitrust Litigation

Off the roster — last appeared 2022-06-15, which usually means the litigation resolved, settled, or closed.

Roster timeline

Each cell is one monthly JPML report (2014-02-19 → 2026-08-03); filled cells are months this MDL was on the pending roster.

Related Antitrust

• MDL 2724 — Generic Pharmaceuticals Pricing Antitrust Litigation — 144 pending
• MDL 2656 — Domestic Airline Travel Antitrust Litigation — 105 pending
• MDL 1720 — Payment Card Interchange Fee and Merchant Discount Antitrust Litigation — 65 pending
• MDL 1917 — Cathode Ray Tube (CRT) Antitrust Litigation — 54 pending
• MDL 3110 — Granulated Sugar Antitrust Litigation — 53 pending
• MDL 2998 — Pork Antitrust Litigation — 51 pending

All antitrust MDLs →

Sources

• JPML Pending MDLs (official)
• Roster report containing this row

Roster presence is our derivation from JPML's monthly PDFs; confirm current status with the court before relying on it.